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Objective.– To assess the efficacy of spa therapy for patients with advanced
primary or post-thrombotic CVD.
Methods.– A single-blind randomized, multicenter, controlled trial. Inclusion
criteria were CVD with skin changes but no ulcer (CEAP: C4a, C4b, or C5). The
treated group had a 3-week spa treatment soon after randomization. All patients
continued their usual care including compression stockings. Follow-up was per-
formed at 6, 12 and 18 months. The main endpoint was the incidence of leg
ulcers at 12 months. Secondary endpoints were VCSS (Venous Clinical Severity
Score), VAS for leg symptoms, CIVIQ2 and EuroQol 5D questionnaires.
Results.– In total, 425 patients were enrolled: 214 in the Spa and 211 in the control
groups. At 1 year, the incidence of leg ulcers was not statistically different. The
VCSS improved significantly in the treatment group; a significant difference
favouring spa treatment was found regarding symptoms; Euro Qol 5D improved
in the treatment group worsened in the control group. A similar pattern was
found for the Chronic Venous Insufficiency Questionnaire 2.
Conclusions.– The incidence of leg ulcers was not reduced but spa therapy
provided a significant improvement in clinical status, symptoms, and quality of
life of patients with advanced CVD
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Objective.– To assess the one-year effectiveness on weight loss of a 3-week
balneotherapy program (BT).
Methods.– A Zelen double consent randomised controlled trial to compare
one-year BMI loss between a 3-week BT program versus usual care (UC) for
overweight or obese patients (BMI: 27–35 kg/m2), associated or not with a die-
tary motivational interview (DMI) during the follow up, using a 2–2 factorial
design. Main analysis was a per protocol analysis comparing patients attending
BT to patients managed by UC, matched on sex, overweight or obese status,
DMI randomisation and a propensity score to attend BT or to be managed by
UC.
Results.– From the 257 patients who completed the follow-up, 70 patients of each
group could be matched. Mean BMI loss was 1.91 kg/m2 [95%CI: 1.46; 2.35]
for the BT patients and 0.20 kg/m2 [−0.24; 0.64] for the UC patients (P < 0.001),
corresponding to a significant BT benefit of 1.71 kg/m2 [1.08; 2.33]. There was
no significant effect of DMI and no interaction with BT or UC. No adverse
reaction was observed for patients attending BT.
Conclusion.– A 3-week BT program provides a significant one-year benefit over
the usual GP dietary advice for overweight and obese patients.
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Background.– Quality of life (QoL) after breast cancer is nowadays a major
challenge, depression symptoms are frequent after treatment, return to activity
has to be favoured; radio-chemotherapy has side effects like weight gain and
fatigue.
Objective.– To test a particular intervention with hydrothermal cares, physical
training and dietary education.
Methods.– In total, 251 non-metastatic patients in complete remission were
included after chemotherapy in a prospective randomised multicenter trial testing
a 2-week intervention in SPA centres (group physical training, dietary education
and balneotherapy). QoL was evaluated with SF36, anxiety and depression with
HAD. Anthropometric measures and QoL evaluations were obtained before
randomisation and every 6 months during 3 years.
Results.– Two hundred and twenty patients were evaluable at 1 year. Intervention
increased significantly SF36 at 6, 12 and 24 months. Effect size (ES) was 0.63.
Anxiety score was shortly minored by intervention (ES: –0.24) and depression
score more durably (ES: –0.45) at 6, 12 and 24 months. The weight control and
level of physical activity were significantly improved, health goods consump-
tion was significantly reduced, return yo work favoured at 12 month in the
intervention group.
Conclusion.– This 2-week group intervention influenced QoL of breast cancer
patients treated by chemotherapy.
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Background.– Preliminary studies suggested that balneotherapy (BT) is
an effective and well-tolerated treatment for generalized anxiety disorder
(GAD).
Objective.– To assess the efficacy of BT in GAD delivered in in 4 spa resorts.
Methods.– We compared BT to paroxetine in terms of efficacy and safety
in a randomized multicentre study lasting 8 weeks. Patients meeting the
diagnostic criteria of GAD (DSM-IV) were recruited. Assessments were
conducted using the Hamilton Rating Scale for Anxiety (HAM-A) and other
scales, by a specifically trained and independent physician. The main end-
point was the change in the total HAM-A score between baseline and
week 8.
Results.– A total of 237 outpatients were enrolled in four centres; 117 were
assigned randomly to BT and 120 to paroxetine. The mean change in HAM-A
scores showed an improvement in both groups with a significant advantage of
BT compared to paroxetine (−12.0 vs −8.7; P < 0.001). Remission (19% vs 7%)
and sustained response (51% vs 28%) rates were significantly higher in the BT
group.
